Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 377 for:    LENALIDOMIDE AND Dexamethasone

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma (PrObe-L)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02692339
Recruitment Status : Recruiting
First Posted : February 26, 2016
Last Update Posted : June 5, 2019
Sponsor:
Information provided by (Responsible Party):
Celgene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 29, 2023
Estimated Study Completion Date : September 29, 2023